Serum levels of osteopontin predict diabetes remission after bariatric surgery.

Abstract:

AIM:Bariatric surgery has been shown to effectively improve glycaemic control in morbidly obese subjects. However, the molecular bases of this association are still elusive and may act independently of weight loss. Here, our retrospective study has investigated the inflammatory molecule osteopontin (OPN) as a potential predictor of type 2 diabetes mellitus (T2DM) remission. METHODS:Baseline serum levels of OPN were analyzed in 41 T2DM patients who underwent bariatric surgery. Anthropometric measures and biochemical variables, including insulin sensitivity indices (HOMA2), were assessed at baseline and at 1 and 3 years after surgery. RESULTS:At baseline, patients who experienced T2DM remission had increased waist circumference, body weight and BMI, and higher serum OPN, compared with non-remitters. Patients with and without T2DM remission improved their lipid and glucose profiles, although insulin resistance indices were only improved in the T2DM remission group. In the overall cohort of both T2DM remission and non-remission patients, baseline circulating levels of OPN significantly correlated with reductions of body weight and BMI over time, and insulin sensitivity improved as well. However, only the HOMA2-%S remained independently associated with serum OPN on multivariate linear regression analysis (B: 0.227, 95% CI: 0.067-0.387, β = 0.831; P = 0.010). Baseline values of OPN predicted 3-year T2DM remission independently of body weight loss, lower BMI and duration of diabetes (OR: 1.046, 95% CI: 1.004-1.090; P = 0.033). CONCLUSION:Although larger studies are still needed to confirm our preliminary results, pre-operative OPN serum levels might be useful for predicting 3-year T2DM remission independently of weight loss in patients undergoing bariatric surgery.

journal_name

Diabetes Metab

journal_title

Diabetes & metabolism

authors

Carbone F,Adami G,Liberale L,Bonaventura A,Bertolotto M,Andraghetti G,Scopinaro N,Camerini GB,Papadia FS,Cordera R,Dallegri F,Montecucco F

doi

10.1016/j.diabet.2018.09.007

subject

Has Abstract

pub_date

2019-09-01 00:00:00

pages

356-362

issue

4

eissn

1262-3636

issn

1878-1780

pii

S1262-3636(18)30178-2

journal_volume

45

pub_type

杂志文章
  • Practical implementation of automated closed-loop insulin delivery: A French position statement.

    abstract::Automated closed-loop (CL) insulin therapy has come of age. This major technological advance is expected to significantly improve the quality of care for adults, adolescents and children with type 1 diabetes. To improve access to this innovation for both patients and healthcare professionals (HCPs), and to promote adh...

    journal_title:Diabetes & metabolism

    pub_type: 杂志文章

    doi:10.1016/j.diabet.2020.10.004

    authors: Tubiana-Rufi N,Schaepelynck P,Franc S,Chaillous L,Joubert M,Renard E,Reznik Y,Abettan C,Bismuth E,Beltrand J,Bonnemaison E,Borot S,Charpentier G,Delemer B,Desserprix A,Durain D,Farret A,Filhol N,Guerci B,Guilhem I,

    更新日期:2020-11-02 00:00:00

  • Temporary multiple cranial nerve palsies in a patient with type 1 diabetes mellitus.

    abstract::Remittent isolated palsy of peripheral or of upper cranial nerves in diabetic patients is well documented, but paralysis of a lower cranial nerve or an isolated branch of any cranial nerve has rarely been reported. In the case described, besides temporary hypoglossal and facial nerve palsies previously, unilateral tem...

    journal_title:Diabetes & metabolism

    pub_type: 杂志文章

    doi:

    authors: Semiz S,Fişenk F,Akçurin S,Bircan I

    更新日期:2002-11-01 00:00:00

  • Fasting and post-oral-glucose-load levels of methylglyoxal are associated with microvascular, but not macrovascular, disease in individuals with and without (pre)diabetes: The Maastricht Study.

    abstract:AIMS:Reactive dicarbonyl compounds, such as methylglyoxal (MGO), rise during an oral glucose tolerance test (OGTT), particularly in (pre)diabetes. Fasting MGO levels are associated with chronic kidney disease (CKD) and cardiovascular disease (CVD) in patients with poorly controlled type 2 diabetes mellitus (T2DM). Yet,...

    journal_title:Diabetes & metabolism

    pub_type: 杂志文章

    doi:10.1016/j.diabet.2020.02.002

    authors: Hanssen NMJ,Scheijen JLJM,Houben AJHM,van de Waarenburg M,Berendschot TTJM,Webers CAB,Reesink KD,van Greevenbroek MMJ,van der Kallen C,Schaper NC,Schram MT,Henry RMA,Stehouwer CDA,Schalkwijk CG

    更新日期:2020-02-10 00:00:00

  • Factors related to CSII compliance.

    abstract::Many studies have demonstrated the metabolic efficacy of continuous subcutaneous insulin infusion (CSII) and particularly a reduction of glycaemic fluctuations in type 1 diabetic patients. Despite this benefit, many patients decide to discontinue the use of CSII. To determine the factors related to discontinuation of ...

    journal_title:Diabetes & metabolism

    pub_type: 杂志文章

    doi:10.1016/s1262-3636(07)70173-8

    authors: Ronsin O,Jannot-Lamotte MF,Vague P,Lassman-Vague V

    更新日期:2005-02-01 00:00:00

  • Low adiponectin levels at baseline and decreasing adiponectin levels over 10 years of follow-up predict risk of the metabolic syndrome.

    abstract:AIM:Adiponectin is the most abundant adipokine and may play a key role in the interplay between obesity, inflammation, insulin resistance and the metabolic syndrome (MetS). Thus, this large population-based cohort investigated whether adiponectin at baseline and/or a decrease in adiponectin during follow-up is associat...

    journal_title:Diabetes & metabolism

    pub_type: 杂志文章

    doi:10.1016/j.diabet.2016.07.027

    authors: Lindberg S,Jensen JS,Bjerre M,Frystyk J,Flyvbjerg A,Jeppesen J,Mogelvang R

    更新日期:2017-04-01 00:00:00

  • Sources of endogenous glucose production in the Goto-Kakizaki diabetic rat.

    abstract::Plasma glucose, insulin and glucose tolerance were quantified in diabetic Goto-Kakizaki (GK) rats (342+/-45 g, n = 5) and compared with weight-matched non-diabetic Wistars (307+/-30 g, n = 8). Compared to Wistars, GK rats had higher fasting plasma insulin (219+/-50 versus 44+/-14 pmol/l, P<0.002) and glucose (9.2+/-2....

    journal_title:Diabetes & metabolism

    pub_type: 杂志文章

    doi:10.1016/j.diabet.2007.03.002

    authors: Sena CM,Barosa C,Nunes E,Seiça R,Jones JG

    更新日期:2007-09-01 00:00:00

  • Improved metabolic control in diabetic adolescents using the continuous glucose monitoring system (CGMS).

    abstract:OBJECTIVE:To determine the utility of the continuous glucose monitoring system (CGMS) as an outpatient procedure to improve management of diabetes in adolescents. RESEARCH DESIGN AND METHODS:Twelve adolescents (mean age: 16.2 +/- 3 years) with poorly controlled type 1 diabetes (HbA(1c) > 8%) were included in this tria...

    journal_title:Diabetes & metabolism

    pub_type: 杂志文章

    doi:10.1016/s1262-3636(07)70076-9

    authors: Schaepelynck-Bélicar P,Vague P,Simonin G,Lassmann-Vague V

    更新日期:2003-12-01 00:00:00

  • When should ultrasonography be used to detect asymptomatic carotid atheroma in diabetic patients?

    abstract:INTRODUCTION:While guidelines for detection of silent myocardial and lower limb ischemia are established, data on screening asymptomatic carotid lesions remain scarce. However, such screening would be costly. Since the prevalence of diabetes increases constantly, it is necessary to keep screening costs low by setting u...

    journal_title:Diabetes & metabolism

    pub_type: 杂志文章

    doi:10.1016/S1262-3636(07)70321-X

    authors: Duval M,Altman JJ

    更新日期:2006-12-01 00:00:00

  • Factors associated with screening for glucose abnormalities after gestational diabetes mellitus: baseline cohort of the interventional IMPACT study.

    abstract:INTRODUCTION:Although it is important to screen women who have had gestational diabetes mellitus (GDM) for abnormal post-partum glucose levels, such testing is rarely performed. The aim of this study was to use data from the first observational phase of the IMPACT study to determine rates of screening within 6 months o...

    journal_title:Diabetes & metabolism

    pub_type: 杂志文章,多中心研究

    doi:10.1016/j.diabet.2013.12.002

    authors: Bihan H,Cosson E,Khiter C,Vittaz L,Faghfouri F,Leboeuf D,Carbillon L,Dauphin H,Reach G,Valensi P

    更新日期:2014-04-01 00:00:00

  • Evaluation of the locus of control in patients with type 2 diabetes after long-term management by group care.

    abstract:AIM:To investigate the locus of control in patients with type 2 diabetes followed by systemic group education (Group Care) and traditional one-to-one care. METHODS:In a post-hoc analysis, two questionnaires were administered to 56 patients who had been followed for 5-7 years by Group Care and 51 controls followed by i...

    journal_title:Diabetes & metabolism

    pub_type: 杂志文章

    doi:10.1016/s1262-3636(07)70250-1

    authors: Trento M,Passera P,Miselli V,Bajardi M,Borgo E,Tomelini M,Tomalino M,Cavallo F,Porta M

    更新日期:2006-02-01 00:00:00

  • Methods for the screening and diagnosis of gestational diabetes mellitus between 24 and 28 weeks of pregnancy.

    abstract::The aim of this review is to provide answers to the question “How does one screen for and diagnose gestational diabetes mellitus (GDM) between 24 and 28 weeks gestation?” Two methods are currently widely used: a one-step approach (the 75g-Oral Glucose Tolerance Test, OGTT) and a two-step approach (the 50g Glucose Chal...

    journal_title:Diabetes & metabolism

    pub_type: 杂志文章,评审

    doi:10.1016/j.diabet.2010.11.008

    authors: Virally M,Laloi-Michelin M

    更新日期:2010-12-01 00:00:00

  • WISE recommendations to ensure the safety of injections in diabetes.

    abstract:AIM:Injections and fingersticks administered to patients with diabetes in health care settings present a risk of blood exposure to the injector as well as other workers in potential contact with sharps. Such exposures could lead to transmission of bloodborne pathogens such as hepatitis and HIV. A recent EU Directive re...

    journal_title:Diabetes & metabolism

    pub_type: 共识发展会议,杂志文章,实务指引,评审

    doi:10.1016/S1262-3636(12)70975-8

    authors: Strauss K,WISE Consensus Group.

    更新日期:2012-01-01 00:00:00

  • Mitochondrial DNA oxidation and manganese superoxide dismutase activity in peripheral blood mononuclear cells from type 2 diabetic patients.

    abstract:AIM:To investigate the balance between parameters of oxidative stress and antioxidant defences in the mitochondria of peripheral blood mononuclear cells (PBMCs) of type 2 diabetic patients with late complications. METHODS:Ten type 2 diabetic patients with late diabetic complications and 10 age-matched healthy voluntee...

    journal_title:Diabetes & metabolism

    pub_type: 杂志文章

    doi:10.1016/j.diabet.2007.10.011

    authors: García-Ramírez M,Francisco G,García-Arumí E,Hernández C,Martínez R,Andreu AL,Simó R

    更新日期:2008-04-01 00:00:00

  • Insulin therapy for type 2 diabetes: premixed or basal-prandial?

    abstract::It is logical to begin type 2 insulin therapy with an injection of an intermediate-acting or a long-acting insulin at bedtime, but one should treat to target, i.e. aim at fasting glycaemias lower than 1.20 g/l to obtain an HbA(1c) close to 7%. Nevertheless, basal insulin therapy does not prevent progression to insulin...

    journal_title:Diabetes & metabolism

    pub_type: 杂志文章

    doi:10.1016/j.diabet.2007.01.005

    authors: Halbron M,Jacqueminet S,Sachon C,Bosquet F,Hartemann-Heurtier A,Grimaldi A

    更新日期:2007-09-01 00:00:00

  • Incretin-based therapy in combination with basal insulin: a promising tactic for the treatment of type 2 diabetes.

    abstract::Incretin therapies such as dipeptidyl peptidase-4 inhibitors (DPP-4Is) and GLP-1 receptor agonists (GLP-1RAs) have become well-established treatments for type 2 diabetes. Both drug classes reduce blood glucose through physiological pathways mediated by the GLP-1 receptor, resulting in glucose-dependent enhancement of ...

    journal_title:Diabetes & metabolism

    pub_type: 杂志文章,评审

    doi:10.1016/j.diabet.2012.08.002

    authors: Vora J,Bain SC,Damci T,Dzida G,Hollander P,Meneghini LF,Ross SA

    更新日期:2013-02-01 00:00:00

  • Pulse pressure strongly predicts cardiovascular disease risk in patients with type 2 diabetes from the Swedish National Diabetes Register (NDR).

    abstract:OBJECTIVES:To analyze pulse pressure (PP) as a risk predictor for coronary heart disease (CHD), stroke and cardiovascular disease (CVD; CHD and/or stroke) in type 2 diabetic patients. METHODS:A total of 11,128 female and male type 2 diabetic patients with known baseline PP values and no CVD, aged 50-74 years, were fol...

    journal_title:Diabetes & metabolism

    pub_type: 杂志文章

    doi:10.1016/j.diabet.2009.04.010

    authors: Nilsson PM,Cederholm J,Eeg-Olofsson K,Eliasson B,Zethelius B,Gudbjörnsdóttir S,Swedish National Diabetes Register (NDR).

    更新日期:2009-12-01 00:00:00

  • Accuracy assessment of online glucose monitoring by a subcutaneous enzymatic glucose sensor during exercise in patients with type 1 diabetes treated by continuous subcutaneous insulin infusion.

    abstract:AIM:Online continuous glucose monitoring (CGM) during physical exercise would be highly useful in patients with insulin-treated diabetes. For this reason, this study assessed whether such a goal could be reached with a subcutaneous 'needle-type' enzymatic sensor. METHODS:Ten patients (five women/five men), aged 51 ± 1...

    journal_title:Diabetes & metabolism

    pub_type: 杂志文章

    doi:10.1016/j.diabet.2012.12.004

    authors: Radermecker RP,Fayolle C,Brun JF,Bringer J,Renard E

    更新日期:2013-05-01 00:00:00

  • Bariatric surgery in young massively obese diabetic patients.

    abstract::Obesity is the most important lifestyle-related risk factor for type 2 diabetes (T2DM). The prevalence of T2DM in adolescents is increasing in parallel with the increasing incidence of major obesity. In adult obese subjects, the greatest degree of T2DM prevention, improvement or recovery has been reported in patients ...

    journal_title:Diabetes & metabolism

    pub_type: 杂志文章,评审

    doi:10.1016/S1262-3636(09)73462-7

    authors: Ciangura C,Basdevant A

    更新日期:2009-12-01 00:00:00

  • A randomised study evaluating the effects of cisapride on glucose variability and quality of life parameters in insulin-dependent diabetes mellitus patients.

    abstract::This study evaluated the effect of cisapride on glycaemic control, well-being and treatment satisfaction in insulin-dependent diabetes mellitus (IDDM) patients with documented moderate to severe glycaemic instability. Thirty-seven patients with glycaemic instability were included in a randomized, double-blind, placebo...

    journal_title:Diabetes & metabolism

    pub_type: 临床试验,杂志文章,随机对照试验

    doi:

    authors: Johansson UB,Wredling RA,Adamson UC,Lins PE

    更新日期:1999-09-01 00:00:00

  • Effect of canagliflozin on liver function tests in patients with type 2 diabetes.

    abstract:AIMS:To report changes in liver function tests observed with canagliflozin, a sodium glucose co-transporter 2 inhibitor, across phase 3 studies in patients with type 2 diabetes, and to examine the relationship between changes in liver function tests and the weight loss and glycaemic improvements observed with canaglifl...

    journal_title:Diabetes & metabolism

    pub_type: 杂志文章,随机对照试验

    doi:10.1016/j.diabet.2015.10.003

    authors: Leiter LA,Forst T,Polidori D,Balis DA,Xie J,Sha S

    更新日期:2016-02-01 00:00:00

  • Inhibitory role of oxytocin on TNFα expression assessed in vitro and in vivo.

    abstract:AIM:Oxytocin administration to diet-induced obese (DIO) rodents, monkeys and humans decreases body weight and fat mass with concomitant improvements in glucose metabolism. Moreover, several studies show an immunomodulatory role of oxytocin in a number of settings (such as atherosclerosis, injury, sepsis). This study ai...

    journal_title:Diabetes & metabolism

    pub_type: 杂志文章

    doi:10.1016/j.diabet.2017.10.004

    authors: Garrido-Urbani S,Deblon N,Poher AL,Caillon A,Ropraz P,Rohner-Jeanrenaud F,Altirriba J

    更新日期:2018-06-01 00:00:00

  • Hyperosmolar nonketotic syndrome with hypernatremia: how can we monitor treatment?

    abstract::We report the case of a 62 year-old symptomatic patient with severe hyperglycemic hyperosmolality associated with hypernatremia. During treatment, the progressive decrease in serum tonicity, which resulted in the amelioration of the neurological symptoms, followed the decrease in serum glucose and mainly the corrected...

    journal_title:Diabetes & metabolism

    pub_type: 杂志文章

    doi:

    authors: Liamis G,Gianoutsos C,Elisaf MS

    更新日期:2000-11-01 00:00:00

  • Vitamin D deficiency, vitamin D receptor gene polymorphisms and cardiovascular risk factors in Caribbean patients with type 2 diabetes.

    abstract:AIM:The prevalence of diabetes in the French West Indies is three times higher than in mainland France. We aimed to assess the associations between vitamin D deficiency, vitamin D receptor (VDR) gene polymorphisms and cardiovascular risk factors in Caribbean patients with type 2 diabetes (T2D). METHODS:In this cross-s...

    journal_title:Diabetes & metabolism

    pub_type: 杂志文章

    doi:10.1016/j.diabet.2011.05.005

    authors: Vélayoudom-Céphise FL,Larifla L,Donnet JP,Maimaitiming S,Deloumeaux J,Blanchet A,Massart C,Munoz-Bellili N,Merle S,Chout R,Bonnet F,Foucan L

    更新日期:2011-12-01 00:00:00

  • Use of GLP-1 receptor agonists for type 2 diabetes treatment intensification after basal insulin failure.

    abstract::Glucagon-like peptide-1 receptor agonists (GLP-1RAs) are part of the armamentarium for the treatment of type 2 diabetes (T2D), although recent guidelines have mainly recommended their use on top of oral treatments when a single or combination of two or three oral hypoglycaemic agents has failed to lower HbA1c levels b...

    journal_title:Diabetes & metabolism

    pub_type: 杂志文章,评审

    doi:10.1016/S1262-3636(17)30071-X

    authors: Joubert M,Reznik Y

    更新日期:2017-04-01 00:00:00

  • Continuous subcutaneous insulin infusion (CSII) using an external insulin pump for the treatment of type 2 diabetes.

    abstract::Continuous subcutaneous insulin infusion (CSII) using an external pump is widely used for the treatment of type 1 diabetes, but has been less evaluated in type 2 diabetes. This review analyzes the open-label as well as randomized controlled studies performed in type 2 diabetic patients. The efficacy of CSII is compare...

    journal_title:Diabetes & metabolism

    pub_type: 杂志文章,评审

    doi:10.1016/j.diabet.2010.08.002

    authors: Reznik Y

    更新日期:2010-12-01 00:00:00

  • The level and determinants of diabetes knowledge in Kuwaiti adults with type 2 diabetes.

    abstract:AIM:To investigate the level of diabetes knowledge in a population with type 2 diabetes (T2D) and a high prevalence of illiteracy, to identify the main gaps in the knowledge and to study the determinants of the knowledge score. METHODS:This cross-sectional survey involved 24 diabetes clinics and Kuwaiti adults with T2...

    journal_title:Diabetes & metabolism

    pub_type: 杂志文章

    doi:10.1016/j.diabet.2008.09.005

    authors: Al-Adsani AM,Moussa MA,Al-Jasem LI,Abdella NA,Al-Hamad NM

    更新日期:2009-04-01 00:00:00

  • Diabetes and hypoglycaemia in young children and mutations in the Kir6.2 subunit of the potassium channel: therapeutic consequences.

    abstract::ATP-sensitive potassium channels (K(ATP)) couple cell metabolism to electrical activity by regulating potassium movement across the membrane. These channels are octameric complex with two kind of subunits: four regulatory sulfonylurea receptor (SUR) embracing four poreforming inwardly rectifying potassium channel (Kir...

    journal_title:Diabetes & metabolism

    pub_type: 杂志文章,评审

    doi:10.1016/S1262-3636(07)70311-7

    authors: Flechtner I,de Lonlay P,Polak M

    更新日期:2006-12-01 00:00:00

  • NOD1 activation induces innate immune responses and insulin resistance in human adipocytes.

    abstract:AIMS:The innate immune-receptor nucleotide oligomerization domain (NOD) protein recognizes intracellular bacterial peptidoglycan. Activation of the innate immune system contributes to the development and progression of insulin resistance. The present study aimed to determine the presence of NOD1 and NOD2 in human adipo...

    journal_title:Diabetes & metabolism

    pub_type: 杂志文章

    doi:10.1016/j.diabet.2012.08.001

    authors: Zhou YJ,Zhou H,Li Y,Song YL

    更新日期:2012-12-01 00:00:00

  • Effectiveness of patient education on glycemic control in insulin treated patients in general practice.

    abstract:OBJECTIVE:To assess the effectiveness of a patient education program on diabetes control. METHODS:A pre-test post-test pre experimental study was performed with 87 insulin treated diabetic patients followed in the chronic disease unit of Kelibia district (Nabeul, Tunisia). Subjects received education in 6 monthly sess...

    journal_title:Diabetes & metabolism

    pub_type: 杂志文章

    doi:10.1016/s1262-3636(07)70207-0

    authors: Jenhani M,Gaha K,Nabouli R,Ghedira A,Ben Abdelaziz A

    更新日期:2005-09-01 00:00:00

  • Management of pregnancy in women with type 1 diabetes mellitus: guidelines of the French-Speaking Diabetes Society (Société francophone du diabète [SFD]).

    abstract:AIM:The clinical guidelines reported by the French-Speaking Diabetes Society (Société francophone du diabète) include updated recommendations for preconceptual planning and care in the management of pregnancy in women with type 1 diabetes mellitus (T1DM). METHODS:The working group included diabetologists, as well as a...

    journal_title:Diabetes & metabolism

    pub_type: 杂志文章,实务指引

    doi:10.1016/j.diabet.2012.02.010

    authors: Bismuth E,Bouche C,Caliman C,Lepercq J,Lubin V,Rouge D,Timsit J,Vambergue A,French-Speaking Diabetes Society.

    更新日期:2012-06-01 00:00:00